BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 23489429)

  • 1. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ehlers-Danlos syndrome type IV in association with a (c.970G>A) mutation in the COL3A1 gene.
    Rebelo M; Ramos L; Lima J; Vieira JD; Tavares P; Teixeira L; Matos A; Costa JN
    Acta Med Port; 2011; 24(6):1079-86. PubMed ID: 22713205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic analysis in the clinical diagnosis of Ehlers-Danlos syndrome type IV].
    Chen B; Guan YQ; Wu XL; Qi YX; Yu HX; Li JX; Zhang J
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1122-4. PubMed ID: 21609597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of three Korean patients with clinical features of Ehlers-Danlos syndrome type IV.
    Yang JH; Lee ST; Kim JA; Kim SH; Jang SY; Ki CS; Kim DK
    J Korean Med Sci; 2007 Aug; 22(4):698-705. PubMed ID: 17728513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.
    Naing BT; Watanabe A; Shimada T
    Biochem Biophys Res Commun; 2011 Feb; 405(3):368-72. PubMed ID: 21219851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
    Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Ehlers-Danlos syndrome: a case with fatal outcome.
    Morais P; Mota A; Eloy C; Lopes JM; Torres F; Palmeiro A; Tavares P; Azevedo F
    Dermatol Online J; 2011 Apr; 17(4):1. PubMed ID: 21549076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ehlers-Danlos syndrome, vascular type: a novel missense mutation in the COL3A1 gene.
    Masuno M; Watanabe A; Naing BT; Shimada T; Fujimoto W; Ninomiya S; Ueda Y; Kadota K; Kotaka T; Kondo E; Yamanouchi Y; Inoue M; Ouchi K; Kuroki Y
    Congenit Anom (Kyoto); 2012 Dec; 52(4):207-10. PubMed ID: 23181496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early venous manifestation of Ehlers-Danlos syndrome Type IV through a novel mutation in COL3A1.
    Wendorff H; Pelisek J; Zimmermann A; Mayer K; Seidel H; Weirich G; Hausser I; Siegel C; Zernecke A; Eckstein HH
    Cardiovasc Pathol; 2013; 22(6):488-92. PubMed ID: 23688910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abdominal emergencies in type IV ehlers-Danlos syndrome].
    Benchellal ZA; Huten N; Danquechin Dorval E; Podeur L; Rahili A; Lemeret S; De Muret A
    Gastroenterol Clin Biol; 1998 Mar; 22(3):343-5. PubMed ID: 9762220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.
    Sadakata R; Hatamochi A; Kodama K; Kaga A; Yamaguchi T; Soma T; Usui Y; Nagata M; Ohtake A; Hagiwara K; Kanazawa M
    Intern Med; 2010; 49(16):1797-800. PubMed ID: 20720362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.
    Pepin M; Schwarze U; Superti-Furga A; Byers PH
    N Engl J Med; 2000 Mar; 342(10):673-80. PubMed ID: 10706896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ehlers-Danlos syndrome type IV and a novel mutation of the type III procollagen gene as a cause of abdominal apoplexy.
    Hassan I; Rasmussen TE; Schwarze U; Rose PS; Whiteman DA; Gloviczki P
    Mayo Clin Proc; 2002 Aug; 77(8):861-3. PubMed ID: 12173720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome.
    Shimaoka Y; Kosho T; Wataya-Kaneda M; Funakoshi M; Suzuki T; Hayashi S; Mitsuhashi Y; Isei T; Aoki Y; Yamazaki K; Ono M; Makino K; Tanaka T; Kunii E; Hatamochi A
    Br J Dermatol; 2010 Oct; 163(4):704-10. PubMed ID: 20518783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoaneurysm of the peroneal artery: presentation of Ehlers-Danlos syndrome type IV.
    Mandeville K; Bicknell C; Tran T; MacDermot K; Renton S
    Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):353-5. PubMed ID: 18485758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.